Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
BioAtla, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
bioatlas.comThe seat is still open. No replacement has been named 16 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Dr. Eric Sievers resigned as Chief Medical Officer of BioAtla on September 25, 2026, to pursue outside interests, but will continue as a consultant through June 30, 2027. His compensation includes a one-time $159,000 payment contingent on the company achieving specific capital raising milestones by December 31, 2026.
Key Takeaways
Chief Medical Officer departure represents a leadership transition that may impact clinical strategy and decision-making
Contingent $159,000 payment tied to capital raising milestones suggests the company is actively pursuing fundraising by year-end 2026
2 more takeaways
Filing Overview
What This Means
BioAtla, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.